معرفی
Miriam Stoppard is affiliated with the Pharmaceutical & Clinical Pharmacy Research Group at Aston Pharmacy School, part of the College of Health and Life Sciences at Aston University. Her research focuses on medication safety in elderly populations, particularly the risks associated with long-term use of anticholinergic drugs and their link to dementia. She has contributed to studies like the 2018 case-control analysis on anticholinergic drugs and dementia risk.
Her work emphasizes the need for healthcare providers to critically review polypharmacy in older adults. No formal academic awards or grants are explicitly listed in the provided text, though her involvement in high-profile media commentary (e.g., Mirror article in 2018) highlights public engagement in healthcare advocacy.
